Allyson Pishko

Dr. Allyson Pishko serves as Assistant Professor of Medicine in the Hematology-Oncology division at the University of Pennsylvania's Perelman School of Medicine. She maintains active clinical practice at the Hospital of the University of Pennsylvania and the Penn Blood Disorders Center, where she sees patients aged 18+ and is currently accepting new appointments. Her dual credentials as MD and MSCE reflect specialized training in clinical epidemiology alongside medical practice.

Her educational pathway includes:

• Medical School: University of Pittsburgh
• Residency: Duke University Medical Center
• Fellowship: Hospital of the University of Pennsylvania

Dr. Pishko's research centers on thrombotic and bleeding disorders with emphasis on immune-mediated conditions. Her work investigates stroke mechanisms in thrombotic thrombocytopenic purpura, cognitive outcomes in blood disorder survivors, and innovative hemophilia treatments including gene therapy. She actively contributes to standardizing diagnostic criteria for rare bleeding disorders through international consensus initiatives.

Analysis of her 2024-2025 publications reveals three dominant research trajectories: 1) Development of bleeding risk prediction models for hospitalized patients, 2) Optimization of therapies for immune-mediated thrombocytopenia across age groups, and 3) Advancement of gene therapy approaches for hemophilia. Her work consistently bridges clinical practice and epidemiological research, often involving multicenter collaborations.

Dr. Pishko maintains exceptional patient satisfaction metrics (4.9/5 from 309 reviews) with patients frequently citing her diagnostic precision and compassionate care. Her clinical practice integrates the latest research findings, particularly in managing complex thrombotic conditions and implementing novel therapeutics like emicizumab for hemophilia B. She actively participates in national hematology networks and contributes to evidence-based guideline development.